Corpus Intelligence IC Memo — ARKANSAS HEART HOSPITAL 2026-04-26 04:05 UTC
IC Memo — ARKANSAS HEART HOSPITAL
Investment Committee Memorandum | AR | 112 beds | Grade C | EBITDA uplift $15.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ARKANSAS HEART HOSPITAL

CCN 040134 | PULASKI, AR | 112 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ARKANSAS HEART HOSPITAL is a 112-bed suburban community hospital in PULASKI, AR with $205.9M in net patient revenue and a 1.2% operating margin. The hospital serves a payer mix of 47.9% Medicare, 3.1% Medicaid, and 49.0% commercial.

Thesis: Undervalued. Our ML models identify $15.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.2% to 8.6% (+736bps).

Net Revenue HCRIS$205.9M
Current EBITDA COMPUTED$2.5M
Operating Margin COMPUTED1.2%
Occupancy HCRIS49.5%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS30.1%
Distress Probability ML48.0%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
32
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 1.2% places it above the state median. Among 32 size-comparable peers (56-224 beds), the median margin is 0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (56-224), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ARKANSAS HEART HOSPITAL (Target)AR112$205.9M1.2%
BAXTER REGIONAL MEDICAL CENTERAR169$282.2M-2.8%
BAPTIST HEALTH MEDICAL CENTER-AR200$278.0M0.2%
ST. VINCENT HOT SPRINGSAR220$258.6M6.6%
WHITE COUNTY MEDICAL CENTERAR179$251.3M3.4%
WHITE RIVER MEDICAL CENTERAR170$247.7M-11.9%
NEA BAPTIST MEMORIAL HOSPITALAR180$246.7M1.0%
CONWAY REGIONAL MEDICAL CENTERAR169$232.9M-14.5%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.3M+210bp18mo
Cost to Collect4.5%2.5%$4.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$132K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.3M
Cost to Collect
$4.1M
Denial Rate Reduction
$4.1M
A/R Days Reduction
$2.5M
Clean Claim Rate
$132K
Total EBITDA Uplift$15.2M
Current EBITDA$2.5M
+ RCM Uplift+$15.2M
Pro Forma EBITDA$17.6M
Current Margin1.2%
Pro Forma Margin8.6%
WC Released (1x)$7.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.8M$167.9M44.07x113.2%
Base (11x exit)10.0x11.0x$3.8M$185.9M48.80x117.6%
Bull Case9.0x11.0x$3.4M$237.2M69.17x133.3%
Bull (12x exit)9.0x12.0x$3.4M$259.8M75.75x137.6%
Bear Case11.0x10.0x$4.2M$90.9M21.68x85.0%
Bear (11x exit)11.0x11.0x$4.2M$101.3M24.18x89.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 56-224 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-12.4% / P50=0.6% / P75=6.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.